Modelling the association between adherence and viral load in HIV-infected patients
- 24 August 2005
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 24 (17) , 2719-2731
- https://doi.org/10.1002/sim.2130
Abstract
The primary objective of this paper is to investigate the effect of adherence to prescribed antiretroviral therapy on virologic response measured repeatedly over time in HIV-infected patients. To this end observations on plasma viral load (HIV RNA) assessed in copies/ml are categorized into four clinically meaningful states, [0 - 50[, [50 - 400[, [400 - 2000[, [2000 and up. A time-dependent continuation ratio model is used to analyse longitudinal ordinal responses. The main challenge lies in modelling dependencies over time and using information contained in the data efficiently to establish a dynamic relation between observed patient adherence and viral load. Among the several measures of adherence investigated, two specifically account for long periods of time without intake. One is derived from the third moment of the inter-dose interval distribution, while the second reflects internal drug exposure using pharmacokinetic parameters. The approach is applied to a clinical trial involving 35 patients who were followed over 12 months. Results demonstrate a significant relation between patient adherence and virologic response. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 12 references indexed in Scilit:
- Electronic monitoring of variation in drug intakes can reduce bias and improve precision in pharmacokinetic/pharmacodynamic population studiesStatistics in Medicine, 2004
- HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infectionAIDS, 2001
- A continuation ratio random effects model for repeated ordinal responsesStatistics in Medicine, 2000
- Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trialsStatistics in Medicine, 2000
- HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology studyAIDS, 1999
- Antiretroviral treatment in 1998The Lancet, 1998
- Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral TherapyThe Journal of Infectious Diseases, 1998
- Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic ResponseAnnals of Internal Medicine, 1997
- Comparing compliance patterns between randomized treatmentsControlled Clinical Trials, 1997
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996